Session Details

The session addresses treatment escalation and de-escalation for stage I TNBC, tailored strategies for stage II and III disease, and the latest advances in managing metastatic TNBC.

Moderator

Marleen Kok, Netherlands Cancer Institute, Amsterdam, Netherlands

Presentation numberED11-01

To escalate or de-escalate treatment for Stage 1 TNBC

Elie Rassy, Gustave Roussy Institute, Villejuif

Presentation numberED11-02

Tailored therapy for stage II and III TNBC

Gustavo Werutsky, LACOG and Hospital Moinhos de Vento, Porto Alegre, Brazil

Presentation numberED11-03

Treatment updates in metastatic TNBC

Sara Tolaney, Dana-Farber Cancer Institute, Boston, MA

Advocate

Janice Cowden, PCDI, Bradenton, FL